Diagnostics and Tools Blue Book October 2024

Crosstree BlueBooks provide an executive review of key health sciences transactions, financial movements, and public market activity. BlueBooks also offer a glimpse of how valuations are changing and how recent trends may affect future transactions.

Highlights from this edition:

• Nusano closed a $115MM Series A Financing, led by Verily Life Sciences, Section 32, Wasatch Venture Partners, and American Cancer Society’s BrightEdge
• Vizgen closed a $150.3MM Series A Financing, led by Arch Venture Partners, Tao Capital Partners, and Northpond Ventures
• Cytovale closed a $100MM Series A Financing, led by Breakout Ventures, Canada Pension Plan Investment Board, Sands Capital Management, Breakout Ventures, and Global Health Investment Corporation